Experienced in Coarctation of the Aorta

Blandine Mondesert

5000 Bélanger Street, 
Montreal, QC, CA 
Experienced in Coarctation of the Aorta
5000 Bélanger Street, 
Montreal, QC, CA 
OverviewLocationsClinical Research

Overview

Blandine Mondesert practices in Montreal, Canada. Ms. Mondesert is rated as an Experienced expert by MediFind in the treatment of Coarctation of the Aorta. Her top areas of expertise are Congenital Heart Disease (CHD), Paroxysmal Supraventricular Tachycardia (PSVT), Arrhythmias, Cardiac Ablation, and Heart Transplant.

Her clinical research consists of co-authoring 121 peer reviewed articles and participating in 6 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 2 articles in the study of Coarctation of the Aorta.

Gender
Female

Locations

5000 Bélanger Street, Montreal, QC, Canada

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

6 Clinical Trials

Aveir Dual-Chamber Leadless i2i IDE Study
Aveir Dual-Chamber Leadless i2i IDE Study
Enrollment Status: Active_not_recruiting
Publish Date: August 15, 2025
Intervention Type: Device
Study Phase: Not Applicable
Blinded Randomized Trial of Anticoagulation to Prevent Ischemic Stroke and Neurocognitive Impairment in AF (BRAIN-AF)
Blinded Randomized Trial of Anticoagulation to Prevent Ischemic Stroke and Neurocognitive Impairment in AF (BRAIN-AF)
Enrollment Status: Terminated
Publish Date: June 15, 2025
Intervention Type: Other, Drug
Study Drug: Rivaroxaban
Study Phase: Phase 3
Multi-Centre, Open-Label, Safety Study of Etripamil Nasal Spray in Spontaneous Episodes of Paroxysmal Supraventricular Tachycardia The NODE-302 Trial (Extension of NODE-301)
Multi-Centre, Open-Label, Safety Study of Etripamil Nasal Spray in Spontaneous Episodes of Paroxysmal Supraventricular Tachycardia The NODE-302 Trial (Extension of NODE-301)
Enrollment Status: Terminated
Publish Date: November 05, 2024
Intervention Type: Drug, Device
Study Phase: Phase 3
Assessment of Primary Prevention Patients Receiving An ICD - Systematic Evaluation of ATP (APPRAISE ATP)
Assessment of Primary Prevention Patients Receiving An ICD - Systematic Evaluation of ATP (APPRAISE ATP)
Enrollment Status: Completed
Publish Date: October 22, 2024
Intervention Type: Device
Study Phase: Not Applicable
Multi-Centre, Randomized, Double-Blind, Placebo-Controlled, Efficacy, and Safety Study of Etripamil Nasal Spray for the Termination of Spontaneous Episodes of Paroxysmal Supraventricular Tachycardia. NODE 301 and RAPID Studies
Multi-Centre, Randomized, Double-Blind, Placebo-Controlled, Efficacy, and Safety Study of Etripamil Nasal Spray for the Termination of Spontaneous Episodes of Paroxysmal Supraventricular Tachycardia. NODE 301 and RAPID Studies
Enrollment Status: Terminated
Publish Date: July 12, 2024
Intervention Type: Drug
Study Drug: Etripamil
Study Phase: Phase 3
Multi-Center, Placebo-Controlled, Dose-Ranging Phase 2 Electrophysiological Study of Intranasal Administration of MSP-2017 for the Conversion of Induced Paroxysmal Supraventricular Tachycardia (PSVT) to Sinus Rhythm
Multi-Center, Placebo-Controlled, Dose-Ranging Phase 2 Electrophysiological Study of Intranasal Administration of MSP-2017 for the Conversion of Induced Paroxysmal Supraventricular Tachycardia (PSVT) to Sinus Rhythm
Enrollment Status: Completed
Publish Date: December 30, 2020
Intervention Type: Drug
Study Phase: Phase 2
View 5 Less Clinical Trials

121 Total Publications

Left ventricular summit ablation for ventricular tachycardia in tetralogy of Fallot.
Left ventricular summit ablation for ventricular tachycardia in tetralogy of Fallot.
Journal: HeartRhythm case reports
Published: September 15, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Mondesert's expertise for a condition
ConditionClose
    View All 10 Advanced Conditions
    View All 18 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile